Question

What is the management of a patient on antiplatelet therapy?

1) ASA - primary prevention
2) ASA - secondary prevention after MI, ACS, stent, stroke, PAD
3) ASA/PLX - <6 weeks post MI/PCI/BMS, stroke, <12months after DES
4) ASA/PLX - low risk situations >3mo after BMS, stroke, uncomplicated MI, PCI without stent

Answer 1

Management of a patient on antiplatelet therapy depends on their medical condition and the reason for the therapy. Aspirin is commonly used for primary and secondary prevention of cardiovascular events, often combined with another antiplatelet drug. The duration of therapy varies depending on the situation.

Step-by-step explanation:

Management of a patient on antiplatelet therapy depends on the individual's medical condition and the reason for the therapy. Antiplatelet therapy, such as aspirin, is commonly used for primary prevention in patients with plaque buildup but with no major artery obstruction. For secondary prevention after a heart attack, stroke, or other cardiovascular events, dual antiplatelet therapy (such as aspirin combined with clopidogrel) may be prescribed. The duration of therapy also varies depending on the specific situation, ranging from less than 6 weeks to more than 3 months.